Nick Bown

5.3k total citations · 1 hit paper
74 papers, 3.1k citations indexed

About

Nick Bown is a scholar working on Molecular Biology, Neurology and Hematology. According to data from OpenAlex, Nick Bown has authored 74 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 30 papers in Neurology and 19 papers in Hematology. Recurrent topics in Nick Bown's work include Neuroblastoma Research and Treatments (30 papers), Acute Myeloid Leukemia Research (13 papers) and Acute Lymphoblastic Leukemia research (11 papers). Nick Bown is often cited by papers focused on Neuroblastoma Research and Treatments (30 papers), Acute Myeloid Leukemia Research (13 papers) and Acute Lymphoblastic Leukemia research (11 papers). Nick Bown collaborates with scholars based in United Kingdom, Belgium and France. Nick Bown's co-authors include Maria Łastowska, Andrew D.J. Pearson, Simon Cotterill, Dominique Plantaz, C. Brinkschmidt, Marian Case, Anthony V. Moorman, Andrew G. Hall, Geneviève Laureys and Holger Christiansen and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Nick Bown

74 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for the diagnosis and management of adult aplastic anaemia

2015 472 citations Nick Bown et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nick Bown United Kingdom	30	1.3k	1.3k	924	663	597	74	3.1k
David S. Viswanatha United States	32	362 0.3×	590 0.5×	1.2k 1.3×	1.1k 1.7×	813 1.4×	133	3.6k
Roberto Giardini Italy	32	569 0.4×	661 0.5×	354 0.4×	1.2k 1.8×	123 0.2×	84	3.2k
Susan Mathew United States	24	149 0.1×	1.1k 0.9×	1.0k 1.1×	785 1.2×	999 1.7×	100	3.3k
Réda Bouabdallah France	28	600 0.5×	880 0.7×	1.5k 1.6×	2.0k 3.0×	307 0.5×	101	4.0k
Amanda F. Cashen United States	29	443 0.3×	629 0.5×	891 1.0×	1.0k 1.6×	193 0.3×	121	2.9k
Fernando Ravagnani Italy	26	234 0.2×	911 0.7×	928 1.0×	1.2k 1.8×	138 0.2×	64	3.1k
J L Harousseau France	22	590 0.5×	503 0.4×	1.1k 1.2×	1.8k 2.7×	350 0.6×	36	3.3k
Karel A. Dicke United States	32	219 0.2×	634 0.5×	2.1k 2.3×	1.3k 2.0×	419 0.7×	108	3.5k
Harald Rieder Germany	31	106 0.1×	1.1k 0.9×	1.0k 1.1×	1.2k 1.9×	934 1.6×	84	3.5k
Charlotte H. Ahern United States	22	571 0.4×	798 0.6×	144 0.2×	756 1.1×	107 0.2×	42	2.0k

Countries citing papers authored by Nick Bown

Since Specialization

Citations

This map shows the geographic impact of Nick Bown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Bown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Bown more than expected).

Fields of papers citing papers by Nick Bown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Bown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Bown. The network helps show where Nick Bown may publish in the future.

Co-authorship network of co-authors of Nick Bown

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Bown. A scholar is included among the top collaborators of Nick Bown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Bown. Nick Bown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ciardullo, Carmela, Jonathan P. Wallis, Helen Marr, et al.. (2023). Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 Inhibition. International Journal of Molecular Sciences. 24(3). 2410–2410. 11 indexed citations

Wallis, Jonathan P., Helen Marr, Scott Marshall, et al.. (2023). SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences. 24(14). 11335–11335. 7 indexed citations

Crosier, Stephen, Debbie Hicks, Ed C. Schwalbe, et al.. (2021). Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics. Neuropathology and Applied Neurobiology. 47(6). 736–747. 8 indexed citations

Chen, Lindi, Mark Brougham, Guy Makin, et al.. (2019). Detection of Circulating and Disseminated Neuroblastoma Cells Using the ImageStream Flow Cytometer for Use as Predictive and Pharmacodynamic Biomarkers. Clinical Cancer Research. 26(1). 122–134. 29 indexed citations

Basta, Nermine O., Guy Makin, Jillian M. Birch, et al.. (2016). Factors associated with recurrence and survival length following relapse in patients with neuroblastoma. British Journal of Cancer. 115(9). 1048–1057. 61 indexed citations

Braekeleer, Étienne De, Nathalie Douet‐Guilbert, David W. Rowe, et al.. (2011). ABL1 fusion genes in hematological malignancies: a review. European Journal Of Haematology. 86(5). 361–371. 66 indexed citations

Windebank, Kevin, Richard Kirk, G. Parry, et al.. (2009). Post cardiac transplantation lymphoproliferative disorder presenting as t(8;14) Burkitt leukaemia/lymphoma treated with low intensity chemotherapy and rituximab. Pediatric Blood & Cancer. 53(3). 392–396. 16 indexed citations

Sulong, Sarina, Anthony V. Moorman, Julie Irving, et al.. (2008). A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. Blood. 113(1). 100–107. 134 indexed citations

Case, Marian, Elizabeth Matheson, Lynne Minto, et al.. (2008). Mutation of Genes Affecting the RAS Pathway Is Common in Childhood Acute Lymphoblastic Leukemia. Cancer Research. 68(16). 6803–6809. 90 indexed citations

10.

Bown, Nick, et al.. (2007). High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays. Cancer Genetics and Cytogenetics. 172(2). 127–138. 29 indexed citations

11.

Roberts, Paul, Susan A. Burchill, Samantha Brownhill, et al.. (2007). Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing's sarcoma family of tumors: A study by the United Kingdom Cancer Cytogenetics and the Children's Cancer and Leukaemia Group. Genes Chromosomes and Cancer. 47(3). 207–220. 42 indexed citations

12.

Hall, Andrew G., et al.. (2004). Loss of Heterozygosity in Childhood Acute Lymphoblastic Leukaemia Detected by Genome-Wide Microarray Single Nucleotide Polymorphism Analysis.. Blood. 104(11). 1088–1088. 1 indexed citations

13.

Bown, Nick, et al.. (2001). 17q gain in neuroblastoma predicts adverse clinical outcome. Medical and Pediatric Oncology. 36(1). 14–19. 56 indexed citations

14.

Bown, Nick. (2001). Neuroblastoma tumour genetics: clinical and biological aspects. Journal of Clinical Pathology. 54(12). 897–910. 91 indexed citations

15.

Vandesompele, Jo, Frank Speleman, Nadine Van Roy, et al.. (2001). Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?. Medical and Pediatric Oncology. 36(1). 5–10. 70 indexed citations

16.

Cuthbert, Gavin, et al.. (2000). Sensitivity of FISH in detection ofMLL translocations. Genes Chromosomes and Cancer. 29(2). 180–185. 26 indexed citations

17.

Bown, Nick, Simon Cotterill, Maria Łastowska, et al.. (1999). Gain of Chromosome Arm 17q and Adverse Outcome in Patients with Neuroblastoma. New England Journal of Medicine. 340(25). 1954–1961. 373 indexed citations

18.

Bown, Nick, David W. Rowe, & M M Reid. (1997). Granulocytic Sarcoma with Translocation (9;11)(p22;q23): Two Cases. Cancer Genetics and Cytogenetics. 96(2). 115–117. 9 indexed citations

19.

Yule, S. Murray, et al.. (1995). Solid alveolar rhabdomyosarcoma with a t(2;13). Cancer Genetics and Cytogenetics. 80(2). 107–109. 9 indexed citations

20.

Bown, Nick, et al.. (1992). Chronic myelomonocytic leukemia with t(13;14) in a child. Cancer Genetics and Cytogenetics. 60(2). 190–192. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact